Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Number of holders
-
325
-
Total 13F shares, excl. options
-
68,661,818
-
Shares change
-
+6,968,049
-
Total reported value, excl. options
-
$7,492,575,765
-
Value change
-
+$726,945,004
-
Put/Call ratio
-
66.13%
-
Number of buys
-
163
-
Number of sells
-
-162
-
Price
-
$109.13
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2018
421 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2018.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 325 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68,661,818 shares
of 105,632,895 outstanding shares and own 65% of the company stock.
Largest 10 shareholders include FMR LLC (10,565,177 shares), Vanguard Group Inc (5,865,323 shares), BlackRock Inc. (4,845,231 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,386,176 shares), SANDS CAPITAL MANAGEMENT, LLC (3,094,767 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,350,144 shares), JANUS HENDERSON GROUP PLC (1,839,594 shares), FRED ALGER MANAGEMENT INC (1,685,638 shares), FIL Ltd (1,568,866 shares), and venBio Select Advisor LLC (1,275,000 shares).
This table shows the top 325 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.